New Delhi, Nov. 2 -- Japanese medical device maker OMRON Healthcare plans to gradually transform its first manufacturing facility in India into a smart manufacturing hub, integrating technology and automation while retaining human intervention in production processes, as it expands its manufacturing footprint in the country.

The company's 24,000-square-metre facility near Chennai, Tamil Nadu, began full-scale production of blood pressure monitors in October 2026. OMRON intends to progressively introduce advanced manufacturing capabilities at the plant, with a focus on improving production efficiency, quality and operational processes.

The India game plan Tsujinaga identified manufacturing innovation and digital health as two key pillars of the company's India strategy.

According to him, the focus extends beyond expanding local manufacturing capacity to strengthening technology-led production capabilities, developing healthcare solutions that leverage digital technologies, and tapping India's potential as both a manufacturing base and a growing market for connected healthcare.

However, the transition will not involve complete automation right away, with human expertise continuing to play an important role in manufacturing operations, Ayumu Okada, president and chief executive officer of OMRON Healthcare, said.

The approach reflects the company's plans to build a manufacturing operation that combines technology-led processes with human oversight, rather than relying entirely on automated production systems.

The facility, operated by OMRON Healthcare Manufacturing India Pvt Ltd, currently has five production lines manufacturing blood pressure monitors for the domestic market. It produces three product series, drawing on manufacturing technologies and quality-control practices developed at OMRON's facilities in Japan and Vietnam.

The company plans to increase the Chennai facility's production capacity tenfold by 2028, targeting annual output of around three million blood pressure monitors. It also intends to introduce nebuliser manufacturing at the site as it expands its home healthcare device portfolio.

The proposed manufacturing upgrade comes as OMRON looks to develop India into a more significant part of its global manufacturing network. While the initial production will cater entirely to domestic demand, the company plans to develop Chennai as a supply base for international markets over the medium to long term.

OMRON's India facility is also expected to strengthen supply-chain resilience by diversifying its manufacturing footprint beyond Vietnam, which has been an important production base for the company.

The expansion will involve strengthening local sourcing and developing supplier relationships in India. The company has said it is working to increase the proportion of components sourced domestically, while also investing in workforce development.

Focus on technology-led expansion The proposed shift towards smart manufacturing comes amid a broader push by global manufacturers to integrate digital technologies into production environments. For OMRON, the transition will need to support the precision and quality requirements associated with medical devices, where manufacturing consistency and reliability are critical.

The company has not outlined a detailed timeline or specific technology investments for the proposed smart manufacturing transition.

Beyond its healthcare business, OMRON has an established presence in industrial automation, a segment that provides technologies for factory automation and manufacturing processes. Its broader India strategy also includes manufacturing innovation and digital health.

The Chennai facility is being established against the backdrop of a substantial opportunity in India's home healthcare market. OMRON estimates that around 300 million people in the country live with hypertension, while fewer than 5% of households regularly use a home blood pressure monitor.

The company aims to increase access to home monitoring devices through local manufacturing, product development and collaboration with healthcare professionals.

For OMRON, the Chennai plant represents more than an expansion of manufacturing capacity. Its gradual evolution into a smart manufacturing hub could also strengthen India's role in the company's global production and supply-chain strategy.

Published by HT Digital Content Services with permission from MINT CIO CIRCLE.